Get the Stockscreener App
2.16
2.26%
-0.05
Beyond Air Inc stock is traded at $2.16, with a volume of 14,673.
It is down -2.26% in the last 24 hours and down -29.87% over the past month.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
See More
Previous Close:
$2.21
Open:
$2.22
24h Volume:
14,673
Relative Volume:
0.32
Market Cap:
$2.13M
Revenue:
$7.68M
Net Income/Loss:
$-34.33M
P/E Ratio:
-0.0245
EPS:
-88.1566
Net Cash Flow:
$-19.17M
1W Performance:
-4.00%
1M Performance:
-29.87%
6M Performance:
-75.74%
1Y Performance:
-95.63%
1-Day Range:
$2.122
$2.2699
1-Week Range:
$2.05
$2.47
52-Week Range:
$2.05
$53.20
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
2.16 | 2.13M | 7.68M | -34.33M | -19.17M | -88.16 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-01-26 | Initiated | Lake Street | Buy |
| Jul-17-25 | Initiated | D. Boral Capital | Buy |
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
View All
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air director Lin Yi-Chien buys $5,761 in company stock By Investing.com - Investing.com South Africa
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Canada
At $2.21 a share, Beyond Air (XAIR) ten percent owner Lin Yi-Chien buys 2,607 shares. - Stock Titan
Top insider buys and sells disclosed on Friday - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Australia
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com UK
A 10% owner buys 20,393 shares of Beyond Air (XAIR) in three direct purchases. - Stock Titan
Ten percent owner Lin Yi-Chien holds 125,000 shares directly in Beyond Air (XAIR). - Stock Titan
Form 3 Beyond Air, Inc. For: Sep 28 Filed by: Lin Yi-Chien - StreetInsider
One holder reports sole voting power over 145,393 Beyond Air (XAIR) shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com Canada
Why Beyond Meat (BYND) Shares Are Getting Obliterated Today - Yahoo Finance
XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada
XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView
Beyond Air at cantors conference: generation 2 is the focus - Investing.com India
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com UK
At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan
XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus
ENvue Medical Announces Reverse Stock Split to Reduce Shares to 923,718 (NASDAQ: FEED) - Kalkine Media
Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com
XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times
Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative
A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - Yahoo Finance
Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com India
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - Yahoo Finance
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com India
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com UK
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
XAIR Q2 2026 Earnings: Narrower Loss Fails to Stem 8.74% Stock DeclineEarnings Sentiment Score - vinanet.vn
Beyond Air Sticks to Revenue Targets as LungFit PH Gen II FDA Decision Nears - finance.biggo.com
Beyond Air Inc (XAIR) Stock News Today - TradingKey
Beyond Air (XAIR) Surges 14.4% to $6.92 as Bulls Defend SupportRisk Parity Rebalance - vinanet.vn
Beyond Air (XAIR) gains 5.30% beneficial owner as Balyasny Asset Management reports 763,266 shares - Stock Titan
XAIR|Beyond Air Inc|Price:7.160|Chg%:+1.110 - TradingKey
Beyond Air (XAIR) Earnings Call zum 1. Quartal des Geschäftsjahres 2027: FDA-Katalysator, Ausblick von 8 Mio. USD für 2026 - TradingKey
Beyond Air (XAIR) Fiscal Q1 2027 Earnings Call: FDA Catalyst, $8M 2026 Outlook - TradingKey
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beyond Air Inc Stock (XAIR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lin Yi-Chien | 10% Owner |
Oct 01 '26 |
Buy |
2.80 |
15,393 |
43,100 |
145,393 |
| Lin Yi-Chien | 10% Owner |
Sep 30 '26 |
Buy |
2.71 |
2,000 |
5,420 |
130,000 |
| Lin Yi-Chien | 10% Owner |
Sep 29 '26 |
Buy |
2.69 |
3,000 |
8,070 |
128,000 |
| Goodman Robert Scott | Chief Executive Officer |
Jul 29 '26 |
Buy |
5.76 |
34,722 |
199,999 |
34,822 |
| MOORHEAD DANIEL J | Chief Financial Officer |
Jul 29 '26 |
Buy |
5.76 |
4,340 |
24,998 |
4,340 |
7.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):